Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. In this study miR-33a/b were identified as ...
Background Over the last few years, there has been increasing attention to the involvement of the central nervous system in Duchenne muscular dystrophy (DMD). The aim of this study was to assess the ...
PARAMUS, N.J., Oct. 14, 2025 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma), a biopharmaceutical leader in rare disease and subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced today that ...
Hosted on MSN
Satellos Bioscience Reports Positive Phase 1 Trial Results for Duchenne Muscular Dystrophy Treatment
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Satellos Bioscience ( (TSE:MSCL)) has ...
More than 10 years after bringing one of the first idiopathic pulmonary fibrosis (IPF) drugs to market, Boehringer Ingelheim is freshening up its leadership in the rare lung disease space with a newly ...
SAN DIEGO — A 9-year-old boy with Duchenne Muscular Dystrophy is enjoying recess on the playground thanks to a custom-built Formula One-style racetrack at Linda Vista Elementary School in San Diego.
It’s not uncommon for breast cancer patients in the rural South to travel hundreds of miles to reach the medical practice run by Dr. Phillip Ley, a cancer surgeon in Jackson, Mississippi. For those ...
Long-term treatment with givinostat in boys with Duchenne muscular dystrophy continues to show a favourable safety and tolerability profile Consistent efficacy demonstrated across age groups MILAN, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback